REDHILL BIOPHARMA LTD. Form 20-F: Annual report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-04-27: Form 20-F; Period of report 2025-12-31; Description 20-F; Document rdhl-20251231x20f.htm.
- 2025-04-10: Form 20-F; Period of report 2024-12-31; Description 20-F; Document rdhl-20241231x20f.htm.
- 2024-04-08: Form 20-F; Period of report 2023-12-31; Description 20-F; Document rdhl-20231231x20f.htm.
- 2023-04-28: Form 20-F; Period of report 2022-12-31; Description 20-F; Document rdhl-20221231x20f.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-04-27 | 20-F | 2025-12-31 | 20-F | rdhl-20251231x20f.htm |
| 2025-04-10 | 20-F | 2024-12-31 | 20-F | rdhl-20241231x20f.htm |
| 2024-04-08 | 20-F | 2023-12-31 | 20-F | rdhl-20231231x20f.htm |
| 2023-04-28 | 20-F | 2022-12-31 | 20-F | rdhl-20221231x20f.htm |
| 2022-03-17 | 20-F | 2021-12-31 | 20-F | rdhl-20211231x20f.htm |
| 2021-03-18 | 20-F | 2020-12-31 | 20-F | rdhl-20201231x20f.htm |
| 2020-03-04 | 20-F | 2019-12-31 | 20-F | rdhl-20191231x20f.htm |
| 2019-02-26 | 20-F | 2018-12-31 | 20-F | rdhl-20181231x20f.htm |
| 2018-02-22 | 20-F | 2017-12-31 | 20-F | rdhl-20171231x20f.htm |
| 2017-02-23 | 20-F | 2016-12-31 | 20-F | rdhl_currentfolio20-f.htm |
| 2016-02-25 | 20-F | 2015-12-31 | FORM 20--F | f20f_022516.htm |
| 2015-02-26 | 20-F | 2014-12-31 | FORM 20-F | f20f_022615.htm |
| 2014-02-25 | 20-F | 2013-12-31 | FORM 20-F | v369113_20f.htm |
| 2013-02-19 | 20-F | 2012-12-31 | ANNUAL REPORT | v335542_20f.htm |